Status:
UNKNOWN
Neurofeedback to Improve Spasticity After Incomplete Spinal Cord Injury
Lead Sponsor:
NHS Greater Glasgow and Clyde
Conditions:
Incomplete Spinal Cord Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
After incomplete spinal cord injury (iSCI), many people still have control over their upper and/or lower limbs, but secondary conditions such as spasticity impair the function they have left. Spastici...
Detailed Description
The proposed study is a pilot exploratory study. It will be carried out on 20 chronic and sub-acute incomplete spinal cord injury participants who will receive five sessions of neurofeedback treatment...
Eligibility Criteria
Inclusion
- Inclusion Criteria for subacute upper limb:
- Aged above 18
- Incomplete injury to the spinal cord, resulting in ASIA level C or D SCI
- Injury occurred no more than six months prior to participation in the study
- Injury level C3 to C7
- Normal or corrected to normal vision
- Spasticity equivalent of MAS level 1+ and above
- Inclusion Criteria for chronic upper limb:
- Aged above 18
- Incomplete injury to the spinal cord, resulting in ASIA level C or D SCI
- Injury occurred more than one year prior to participation in the study
- Injury level C3 to C7
- Normal or corrected to normal vision
- Spasticity equivalent of MAS level 1+ and above
- Live in Greater Glasgow and Clyde area
- Inclusion Criteria for subacute lower limb:
- Aged above 18
- Incomplete injury to the spinal cord, resulting in ASIA level C or D SCI
- Injury occurred no more than six months prior to participation in the study
- Injury level T1 to L1
- Normal or corrected to normal vision
- Ability to walk \> 10 meters (assisted or unassisted), if ASIA level D
- Spasticity equivalent of MAS level 1+ and above
- Inclusion Criteria for chronic lower limb:
- Aged above 18
- Incomplete injury to the spinal cord, resulting in ASIA level C or D SCI
- Injury occurred more than one year prior to participation in the study
- Injury level T1 to L1
- Normal or corrected to normal vision
- Ability to walk \> 10 meters (assisted or unassisted), if ASIA level D
- Spasticity equivalent of MAS level 1+ and above
- Live in Greater Glasgow and Clyde area
Exclusion
- Exclusion Criteria for subacute groups:
- Participation in any other neurofeedback intervention group
- Inability to understand the task
- Self-reported neurological disorders e.g. previously confirmed peripheral nerve injury or brain injury
- General poor health due to secondary consequences of injury
- Conditions contra-indicative of neurostimulator usage (implanted devices, sensitive skin sores in the upper and lower extremities, pregnancy, severe autonomic dysreflexia)
- History of epilepsy
- Inability to sit for 1.5 hours
- Inability to speak and/or understand English
- Exclusion Criteria for chronic groups:
- Participation in any other neurofeedback intervention group
- Inability to understand the task
- Self-reported neurological disorders e.g. previously confirmed peripheral nerve injury or brain injury
- General poor health due to secondary consequences of injury
- Conditions contra-indicative of neurostimulator usage (implanted devices, sensitive skin sores in the upper and lower extremities, pregnancy, severe autonomic dysreflexia)
- History of epilepsy
- Inability to sit for 1.5 hours
- Inability to speak and/or understand English
- Live outside Greater Glasgow and Clyde area
Key Trial Info
Start Date :
August 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04849676
Start Date
August 31 2021
End Date
July 1 2023
Last Update
April 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Elizabeth University Hospital, Queen Elizabeth National Spinal Injurie Unit
Glasgow, Glasgow City, United Kingdom, G51 4TF